Paid-members only Nvidia Featured Espionage Found Nvidia's Single Point of Failure. It Was Never the Chips. Eight days, a suspected honeytrap, a board reportedly weighing Jensen Huang's removal, a trillion dollars gone. The smuggling economy, the Beijing paradox, the $225-vs-$300 key-man math, and our own position handled honestly.
Macro Featured The First Boomers Are Turning 80. America Can't Afford What Comes Next. Nursing home care runs a median $9,825 a month, Medicare doesn't cover it, and the largest generation in American history is aging straight into the bill. Who pays — and where the money is already moving.
Members only Defence Featured The Pentagon's Biggest Cyber Rule Came Due This Week. It Never Showed Up. Seven years of rulemaking were supposed to culminate November 10, when third-party cyber certification became the price of admission to defense contracts. The deadline passed in silence — and an entire compliance economy is repricing around the gap.
Members only Energy Featured Aluminum Costs 70% More in America Than Anywhere Else. The Smelters Still Won't Come Back. The Midwest premium is above a dollar a pound and America's most famous idled smelter just became an AI data center. The tariff wall raised prices, not production — the power auction explains why.
Paid-members only Markets Featured $NBIS Reports Thursday With Options Pricing a 17% Swing: The $3 Billion Run Rate Chasing a $7 to $9 Billion Year-End Promise, $40 Billion of Contracts From Two Customers, and the Zones From $111 to $180 Nebius fell 12% in a week, bounced 15% premarket on CoreWeave's beat, and reports Q3 Thursday morning with options pricing a 17% move. The ATM dilution math, the $8 billion half-year capex bill, the two-customer concentration, and scenario zones from $111 to $180.
Members only Markets Featured A Continent of 1.5 Billion People Issued 20 Corporate Bonds Last Year The OECD just quantified global finance's strangest asymmetry: Africa's entire corporate bond market is $35 billion and shrinking — while its stock markets beat every emerging-market benchmark. Where the gap closes is the trade.
Paid-members only Finance Featured Private Equity Needed a New Buyer. Washington Just Nominated Your 401(k). The final rule opening America's $10.8 trillion 401(k) market to private equity just landed at the White House. The industry lobbying for it can't return cash to its existing investors — and the Supreme Court, not the Labor Department, will decide whether the money actually moves.
Paid-members only Markets Featured $QBTS Reported Earnings Three Days After Printing a 52-Week Low: The $4.5 Million Quarter Behind the $4.2 Billion Valuation, the 1,221% Backlog Number Doing the Heavy Lifting, and the Zones From $8.48 to $13 D-Wave hit a 52-week low Thursday, bounced 27%, then reported Q3 this morning: $4.5M revenue, $503M cash, backlog up 1,221%, and a widening EBITDA loss. The dilution engines, the burn clock, and scenario zones from $8.48 to $13.
Infrastructure Featured Voters Just Rebuked the Data-Center Boom. The Senate's First Response: Build Faster. The first major vote after the midterm wipeout was a 73-25 move to fast-track the biggest permitting overhaul in a generation. Who wins, who pays, and why the lame-duck clock is the whole story.
Members only Energy Featured The Rare Earth Truce Had One Day to Live. Beijing Gave It Two Months. China waited until 24 hours before expiry to extend the suspension of its October 2025 rare earth export controls — and only until January 10, 2027, the same day the tariff truce ends. Every U.S.-China deadline now converges on a single date.
Markets Featured The Cybertruck Is Dead. Tesla Just Raised the Price Anyway. Tesla will end Cybertruck production in mid-2027 after selling roughly a tenth of what the line was built for. The wind-down — and the 32% price jump that followed — says more about where Tesla is going than any earnings call.
Finance Featured The Drugstore Era Is Over. CVS Just Made It Official. CVS is splitting its 9,000 drugstores from Aetna and Caremark, unwinding the biggest vertical-integration bet in American healthcare. Why it's happening now, and what investors should watch before 2028.
Members only Markets Featured Bitcoin ETFs Just Erased a Year of Inflows. Who's Left to Buy? US spot bitcoin ETFs just flipped to net outflows for 2026 after a $1.28 billion exit week. Every leg of this cycle was carried by a different buyer — and the flow data now shows who's left.
Paid-members only Markets Featured $FLY Hit an All-Time Low 24 Hours Before Landing a $1.3 Billion Engine Deal: What the Headline Number Is Really Made Of, the Burn Clock It Resets, and the Zones From $14.44 to $26.86 Into Tuesday's Earnings Firefly Aerospace fell to $14.44 Wednesday, then jumped 36.8% Friday on a $1.3B AST SpaceMobile engine deal and a NASA CLPS 2 seat, with Q3 earnings due Tuesday after the close. The $400M cash vs locked-stock split, the $106M quarterly burn it lands on, and scenario zones from $14.44 to $26.86.
Members only Space Economy Featured The ISS Comes Down in 2030. The Race to Replace It Just Got a Deadline. NASA's final solicitation for commercial space stations is out and bids are due December 8. Four companies are in, the crew-transport math is unsolved, and only one public stock carries direct exposure to the April award.
Paid-members only Markets Featured Top 10 Stocks We're Watching This Week — Inflation Week Edition Tuesday's CPI arrives with no annual rate, CoreWeave prints Tuesday night, Take-Two reports ten days before GTA VI ships, and Cisco and Applied Materials close the week Thursday. Brent just crashed from $117 to $98. Nine of ten report earnings; the tenth is the policy trade the midterms created.
Paid-members only Investing Featured The First Drug That Might Slow Huntington's Finally Has an FDA Date. The Market Sold the News. uniQure's one-time gene therapy just got priority review and a May 1, 2027 decision date — the first in Huntington's history. The stock fell anyway. At $750 million of enterprise value net of cash, the gap between milestone and market is the trade.
Members only Macro Featured The Last Major Central Bank Just Joined the War Economy The Bank of England raised rates for the first time since 2023 — 8 to 1, with the dissent wanting double. Gilts above 5%, a 25% energy-cap jump landing in January, and a December meeting that is suddenly live.
Macro Featured America Is Hiring Again. The Unemployed Can't Tell. October's 165,000-job blowout hid the longest average job search since 2016. The labor market has split in two — and the low jobless-claims data is part of the illusion.
Members only Markets Featured Every Central Bank Is Hiking. Mexico Just Cut. The same day the Bank of England joined the global hiking cycle, Banxico defied every forecast with a 3–2 cut to 6.25%. The peso fell, stocks rallied, and the carry cushion over the Fed is down to 225 basis points. Here's what the divergence is pricing.
Members only Geopolitics Featured The 1.5°C Era Is Over. The Fight Over Who Pays for What Comes Next Starts Monday. COP31 opens Monday in Antalya as the first climate summit of the overshoot era: the 1.5°C target is gone, the U.S. is out of Paris, and a $7.5 trillion finance gap is the only agenda item that matters for markets.
Members only Macro Featured 76 Million Americans Just Got a Raise. The Fund That Pays It Has Six Years Left. Social Security's 3.6% COLA is the largest since 2023 — and a live readout of reaccelerating inflation. The fund paying it burned $200 billion last year, and the official clock now stops in 2032.
Markets Featured Nobody Voted to End the AI Trade. Wall Street Sold It Anyway. A $2.9 trillion single-session wipeout, the Nasdaq in correction, and semiconductors' worst day since 2020. Inside the three forces that broke the AI trade on Thursday — and what today's jobs report means for the bounce.
Paid-members only Markets Featured $IONQ Printed a $564 Million Profit at a 52-Week Low While Losing $433 Million From Operations: The Warrant Math, the Real Growth Rate, and the Wall at $69.46 IonQ beat on revenue, raised 2026 guidance to $515M, and reported its first GAAP profit, a day after hitting a 52-week low. The $896M warrant gain that created the profit, the acquired half of the 336% growth, the $3.7B war chest, and scenario zones from $24.92 to $69.46.
Paid-members only Investing Featured On Black Friday, the FDA Rules on a Disease That Has Never Had a Drug BridgeBio lost 72% in a day in 2021. Five years later it runs a $1 billion-rate heart drug and faces three FDA decisions in seven months — starting November 27, with the first potential approval for any form of limb-girdle muscular dystrophy.
